Mercodia AB (Uppsala, Sweden) provide high quality immunoassay kits (ELISAs) for clinical and research use. These are used in human and other mammalian models in the fields of cardiovascular disease, obesity and diabetes.
Label-free characterization of antibody-antigen interactions provides important, high quality data for decision-making during product development and production in this type of biotechnology environment.
Characterization of antibody binding to target antigens makes valuable contributions to multiple aspects of Mercodia's workflow. Eleni Karamihos kindly shared her experiences with us after working with Biacore X100:
We gratefully acknowledge Eleni Karamihos, Robert Gunnarsson and Patrik Lindstedt (Mercodia AB) for their contributions.